What is the ROCE (Return on Capital Employed) of ABIOMED this year?
The ROCE of ABIOMED is 0.17 undefined this year.
ABIOMED ROCE 2025
ABIOMED ROCE
0.17
Ticker
ABMD
ISIN
US0036541003
WKN
873886
In 2025, ABIOMED's return on capital employed (ROCE) was 0.17, a 0% increase from the 0 ROCE in the previous year.
ABIOMED Aktienanalyse
What does ABIOMED do?
Abiomed Inc. is one of the most innovative companies in the medical technology industry. It was founded in 1981 and is headquartered in Danvers, Massachusetts. The company specializes in the development, manufacturing, and marketing of medical devices aimed at saving or improving patients' lives. Abiomed started as a small company focused on implantation technology for cardiac arrhythmias. However, the company soon recognized the need to concentrate on providing solutions for cardiac intensive care. Today, Abiomed is a leader in the field of cardiopulmonary support systems and offers innovative devices to support the heart. Abiomed's business model revolves around leveraging its expertise in medical technology for cardiology interventions and intensive care and bringing innovative products to market. The company has industry experts and doctors on its team who contribute to the development and manufacturing of products. This highest level of professionalism is also reflected in the distribution channels Abiomed utilizes, with a focus on delivering its products to clinics specialized in critical medical interventions. Abiomed is divided into various business segments that concentrate on the medical devices the company offers. One of these segments is the Impella portfolio, which focuses on heart pumps for acute heart failure. These pumps are capable of supporting the heart during cardiological intervention by pumping blood into the heart while artificially ventilating it. The Impella portfolio is recognized as a standard in cardiac intensive care. Another important area for Abiomed is product development. The company heavily invests in researching and developing new products to meet the current demand in cardiology on the market. Abiomed is aware that rapid development of new products can provide a competitive advantage and, therefore, is an essential part of its business model. The technology offered by Abiomed is revolutionary and allows for the treatment of patients with acute heart failure, which was previously difficult or impossible. This is a significant milestone for the company and the healthcare industry in general. Abiomed is aware of its responsibility towards patients, doctors, and hospitals and is continuously working to develop innovative solutions for the healthcare industry. In summary, Abiomed Inc. is a leading company in the medical technology industry that focuses on cardiology intervention and intensive care. The company is innovative and offers products that can save and improve patients' lives. The Impella portfolio, specializing in acute heart failure, is an important part of its business model. Abiomed heavily invests in research and development to consistently provide innovative solutions to its customers. ABIOMED ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling ABIOMED's Return on Capital Employed (ROCE)
ABIOMED's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing ABIOMED's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
ABIOMED's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in ABIOMED’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about ABIOMED stock
How has the ROCE (Return on Capital Employed) of ABIOMED developed compared to the previous year?
The ROCE of ABIOMED has increased by 0% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of ABIOMED?
A high Return on Capital Employed (ROCE) indicates that ABIOMED has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of ABIOMED?
A low ROCE (Return on Capital Employed) can indicate that ABIOMED has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from ABIOMED impact the company?
An increase in the ROCE of ABIOMED can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of ABIOMED affect the company?
A decrease in ROCE of ABIOMED can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of ABIOMED?
Some factors that can affect ABIOMED's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of ABIOMED so important for investors?
The ROCE of ABIOMED is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can ABIOMED take to improve the ROCE?
To improve the ROCE, ABIOMED can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does ABIOMED pay?
Over the past 12 months, ABIOMED paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ABIOMED is expected to pay a dividend of 0 USD.
What is the dividend yield of ABIOMED?
The current dividend yield of ABIOMED is .
When does ABIOMED pay dividends?
ABIOMED pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of ABIOMED?
ABIOMED paid dividends every year for the past 0 years.
What is the dividend of ABIOMED?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is ABIOMED located?
ABIOMED is assigned to the 'Health' sector.
Wann musste ich die Aktien von ABIOMED kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ABIOMED from 8/3/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/3/2025.
When did ABIOMED pay the last dividend?
The last dividend was paid out on 8/3/2025.
What was the dividend of ABIOMED in the year 2024?
In the year 2024, ABIOMED distributed 0 USD as dividends.
In which currency does ABIOMED pay out the dividend?
The dividends of ABIOMED are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The ABIOMED stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von ABIOMED
Our stock analysis for ABIOMED Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ABIOMED Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
